S.Amdt.2125 - To ensure that adequate information is disseminated to health care providers and payors about the potential benefits and risks of medical products on all patient populations, particularly underrepresented subpopulations, including racial subgroups.
About This Bill
Passed
Latest Action · May 23, 2012
Amendment SA 2125 agreed to in Senate by Unanimous Consent.